Goldman Sachs Downgrades American Renal Associates (ARA) to Sell

November 21, 2016 6:33 AM EST
Get Alerts ARA Hot Sheet
Price: $19.63 -1.01%

Rating Summary:
    3 Buy, 0 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 22 | Down: 32 | New: 34
Trade ARA Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Goldman Sachs downgraded American Renal Associates (NYSE: ARA) from Neutral to Sell with a price target of $22.

For an analyst ratings summary and ratings history on American Renal Associates click here. For more ratings news on American Renal Associates click here.

Shares of American Renal Associates closed at $24.10 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Goldman Sachs

Add Your Comment